---

Clinical Report: Rare Occurrence of Multisystem Inflammatory Syndrome in Children (MIS-C)

Background

Multisystem inflammatory syndrome in children (MIS-C) is a serious post-infectious condition associated with COVID-19, presenting with significant morbidity.

Data Highlights

Recent studies show that the incidence of MIS-C has varied with different COVID-19 variants, with a notable increase during the Delta variant surge. The overall mortality rate associated with MIS-C remains low, but severe complications, particularly cardiovascular, are common. Ongoing research is focusing on long-term outcomes and the potential for chronic health issues in affected children.

Key Findings

• MIS-C was first identified in April 2020 and can lead to severe cardiovascular complications.

• Cardiac involvement occurs in up to 80% of MIS-C patients, including left ventricular dysfunction and coronary artery dilation.

• Cardiovascular manifestations of MIS-C were most severe following Delta variant infections.

• There has been a noted decline in the severity of MIS-C cases with the emergence of Omicron variants.

• Recent data indicates that cardiovascular features remain prominent even in the Omicron era.

• Most echocardiographic abnormalities resolve within 6-9 months post-MIS-C, but some subclinical dysfunction may persist longer.

Clinical Implications

Healthcare providers should be aware of the evolving nature of MIS-C and its cardiovascular implications, particularly as new variants emerge. Continuous monitoring and updated clinical guidelines are essential for managing these cases effectively.

Related Resources & Content

1. International Journal of Infectious Diseases, 2026 -- Incidence trends, outcomes, and factors associated with mortality in multisystem inflammatory syndrome in children: A nationwide study in Thailand during 2021-2023

2. Open Forum Infectious Diseases, 2026 -- Multisystem Inflammatory Syndrome in Children: Assessment, Treatment Strategies, and Prognosis

3. Pediatric Cardiology, 2026 -- Long-term CMR Findings in Pediatric COVID-19 Related Myocarditis

4. Mayo Clinic, 2026 -- Mayo Clinic Q&A podcast: COVID-19 and multisystem inflammatory syndrome in children

5. CDC, 2026 -- Case Definitions and Reporting | MIS | CDC

6. JACC, 2026 -- MULTISYSTEM INFLAMMATORY SYNDROME IN CHILDREN (MIS-C) ASSOCIATED WITH RECENT COVID-19 OMICRON SUBTYPES IS RARE BUT INVOLVES SEVERE CARDIOVASCULAR FEATURES

7. CDC, 2026 -- Clinical Treatment of Multisystem Inflammatory Syndrome in Children | MIS | CDC

8. Case Definitions and Reporting | MIS | CDC

9. 26-A-7844-ACC MULTISYSTEM INFLAMMATORY SYNDROME IN CHILDREN (MIS-C) ASSOCIATED WITH RECENT COVID-19 OMICRON SUBTYPES IS RARE BUT INVOLVES SEVERE CARDIOVASCULAR FEATURES | JACC

10. Clinical Treatment of Multisystem Inflammatory Syndrome in Children | MIS | CDC

---